Regenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy Read more 

Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development Read more 

Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities Read more 

About Charles Muriuki

This author has not yet filled in any details.
So far Charles Muriuki has created 2 blog entries.
Go to Top